It was shown that the level of UCHL1 expression determined in tumor tissue by the immunohistochemical method was associated with an unfavorable outcome in patients with LC and breast cancer, and that this protein could serve as a target for targeted therapy [33]. The gene discussed is UCHL1; the disease is neoplasm.